BrainXell is launching its human induced pluripotent stem cell (iPSC)-derived sensory neurons, the company announced recently.

According to a release, the iPSC-derived sensory neurons are a scalable human cellular platform engineered to support reproducible functional studies in pain biology, sensory transduction and ion channel pharmacology.

“Human sensory neuron biology is highly complex, particularly when studying functional responses associated with pain signaling and ion channel activity,” BrainXell Applications Scientist Semra Sahin, Ph.D., said in a statement. “Our goal with this platform was to deliver a reproducible human model that combines strong molecular identity with functional responsiveness, enabling researchers to generate more predictive data across pharmacology and translational neuroscience workflows.”

The biotech company will showcase its newly launched product in an April 2 presentation on Scientist.com.